Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06653400 · ClinicalTrials.gov registry record · Phase 1
Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy
A Phase 1 study of Analgesia and Abnormal Uterine Bleeding, sponsored by Icahn School of Medicine at Mount Sinai.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06653400: Recruiting Phase 1 study of Analgesia and Abnormal Uterine Bleeding, sponsored by Icahn School of Medicine at Mount Sinai.
NCT06653400 is a Phase 1 study of Analgesia and Abnormal Uterine Bleeding that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 60 participants, below the 90-participant average among 19 other Analgesia trials with a reported enrollment target (33% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06653400, a Phase 1 study of Analgesia and Abnormal Uterine Bleeding, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
A randomized double-blind placebo controlled trial comparing the effect of a combined ketorolac and lidocaine paracervical block with a standard lidocaine paracervical block on procedure related pain with office hysteroscopies.
Primary Outcome
Pain as measured on a 100 mm visual analogue scale (VAS) with cervical dilation. Full scale scored from 0-100, higher score indicates more pain.
Conditions Studied
Interventions
- DRUG Lidocaine
- PROCEDURE paracervical block
- DRUG ketorolac
Study Locations (1)
New York
- Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-02-27 |
| Est. Completion | 2026-09-01 |
| Phase | Phase 1 |
What NCT06653400 shows while recruiting
NCT06653400 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 90-participant average among 19 other Analgesia trials with a reported enrollment target (33% lower).
The record links to 3 conditions, with Analgesia appearing as the primary indexed condition, and to 3 interventions - of which Lidocaine is the first listed.
NCT06653400 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06653400 about?
NCT06653400 is a clinical study titled "Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy". A randomized double-blind placebo controlled trial comparing the effect of a combined ketorolac and lidocaine paracervical block with a standard lidocaine paracervical block on procedure related pain with office hysteroscopies.
What is the current status of trial NCT06653400?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2025-02-27. Estimated completion is 2026-09-01.
What conditions does trial NCT06653400 study?
This clinical trial studies the following conditions: Analgesia, Abnormal Uterine Bleeding, Paracervical Block.
What interventions are being tested in trial NCT06653400?
The interventions under investigation include: Lidocaine (DRUG), paracervical block (PROCEDURE), ketorolac (DRUG).
Who is sponsoring clinical trial NCT06653400?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06653400 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Analgesia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06653400's enrollment target sits among peer trials
60 14th of 19 higher than 5 of 19 other Analgesia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Analgesia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TENS Unit for Analgesia During IUD Insertion
RECRUITING · NA
-
Adductor Canal Block and IPACK Block vs. Isolated Adductor Canal Block for Post-Operative Analgesia Following HTO/DFO/TTO
RECRUITING · Phase 4
-
Transversus Abdominis Plane Block Compared to Local Anesthetic Wound Infiltration in Gynecologic Oncology Surgery
RECRUITING · Phase 4
-
Impact of the NeuroCuple Device on Pain Management After Cesarean Delivery
RECRUITING · NA
-
Evaluation of Pain Management After Surgery When Using Exparel in the Pediatric Population
RECRUITING · Phase 2
-
Transcutaneous Electrical Nerve Stimulation for Post-Cesarean Pain Control
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI